Evidence-Based Complementary and Alternative Medicine [110] H. Li, Y. Gao, C. D. Freire, M. K. Raizada, G. M. Toney, and C. Sumners, “Macrophage migration inhibitory factor in the PVN attenuates the central pressor and dipsogenic actions of angiotensin II,” The FASEB Journal, vol. 20, no. 10, pp. 1748– 1750, 2006. [111] J. Liu, J. D. Farmer Jr., W. S. Lane, J. Friedman, I. Weissman, and S. L. Schreiber, “Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes,” Cell, vol. 66, no. 4, pp. 807–815, 1991. [112] S. G. Oliver, M. K. Winson, D. B. Kell, and F. Baganz, “Sys- tematic functional analysis of the yeast genome,” Trends in Biotechnology, vol. 16, no. 9, pp. 373–378, 1998. [113] S. Agnolet, J. W. Jaroszewski, R. Verpoorte, and D. Staerk, “1H NMR-based metabolomics combined with HPLC-PDA- MS-SPE-NMR for investigation of standardized Ginkgo biloba preparations,” Metabolomics, vol. 6, no. 2, pp. 292– 302, 2010. [114] Q. Zhang, G. J. Wang, J. Y. A et al., “Application of GC/MS-based metabonomic proﬁling in studying the lipid- regulating eﬀects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats,” Acta Pharmacologica Sinica, vol. 30, no. 12, pp. 1674–1687, 2009. [115] G. Tan, Z. Lou, J. Jing et al., “Screening and analysis of aconitum alkaloids and their metabolites in rat urine after oral administration of aconite roots extract using LC- TOFMS-based metabolomics,” Biomedical Chromatography, vol. 25, no. 12, pp. 1343–1351, 2011. [116] S. Yan, B. Wu, Z. Lin et al., “Metabonomic characterization of aging and investigation on the anti-aging eﬀects of total ﬂavones of Epimedium,” Molecular BioSystems, vol. 5, no. 10, pp. 1204–1213, 2009. [117] Q. Zhang, F. Zuo, N. Nakamura, C. M. Ma, and M. Hattori, “Metabolism and pharmacokinetics in rats of ganoderiol F, a highly cytotoxic and antitumor triterpene from Ganoderma lucidum,” Journal of Natural Medicines, vol. 63, no. 3, pp. 304–310, 2009. 13